MARPE in Adults:
Breaking the Age Barrier
in Palatal Expansion
Discover how miniscrew-assisted rapid palatal expansion achieves true skeletal changes in adult patients without surgical intervention, with 95% suture separation success rates.
TL;DR MARPE in adults bypasses the fused midpalatal suture through miniscrew skeletal anchorage, achieving true skeletal expansion without surgical intervention. Recent RCT data show 95% midpalatal suture separation rates and greater nasal width gains compared to conventional RPE, making MARPE a viable non-surgical alternative for adult maxillary transverse deficiency.
Adult palatal expansion remains one of the most debated topics in contemporary orthodontics, largely because skeletal maturity was once considered an insurmountable barrier. Dr. Mark Radzhabov reviews the evidence-based MARPE protocol—patient selection criteria, miniscrew biomechanics, and expected skeletal response in skeletally mature patients—drawing on more than a decade of clinical practice and the most current evidence. This article explains why MARPE has become a game-changing alternative to surgical expansion in adult patients and how to implement it into your practice at ortodontmark.com.
What Is MARPE?
Understanding the Paradigm Shift
MARPE is a non-surgical technique that uses temporary palatal miniscrews to anchor a rapid expansion appliance, bypassing the need for surgical manipulation of the midpalatal suture in skeletally mature patients. For decades, the fused midpalatal suture was considered an anatomical “wall”—making conventional rapid palatal expansion (RPE) ineffective in adults and leaving SARPE (surgically assisted rapid maxillary expansion) as the only viable option. MARPE fundamentally changes this equation by providing absolute skeletal anchorage independent of the dentition, allowing the expansion force to act directly on the maxillary bones rather than being dissipated through tooth movement and alveolar bending. The technique emerged from clinical observations that the midpalatal suture, while ossified, retains biological responsiveness to properly vectored mechanical force when applied at the skeletal level. A prospective randomized clinical trial comparing conventional RPE to MARPE in adolescents and young adults demonstrated a 95% midpalatal suture separation rate in the MARPE group, with significantly greater increases in nasal width at the molar region immediately after expansion and after consolidation. This evidence repositioned MARPE not merely as a “surgical alternative” but as a superior biomechanical approach to adult maxillary expansion.
Why MARPE Works in Skeletal
Maturity
The fundamental advantage of miniscrew-assisted rapid palatal expansion lies in its circumvention of the dental unit. Conventional RPE, even with optimal force application, must overcome the resistance of the midpalatal suture while simultaneously moving the maxillary teeth buccally—a phenomenon known as dentoalveolar compensation. In growing patients, this compensation is managed by the remaining skeletal plasticity; in adults, it becomes the dominant response, with the suture remaining largely closed and the teeth flaring excessively. MARPE eliminates this compensation by applying expansion force directly to the skeletal structure through miniscrews positioned in the hard palate, usually in the anterior-lateral or mid-palatal regions. This creates a true separation vector at the suture itself, independent of tooth position. The biological response involves microfracturing at the suture followed by rapid ossification—a process that occurs even in fully ossified palates when the force vector is perpendicular to the suture line and magnitude is appropriate (typically 200–300 N initial force). Adult bone retains the capacity for remodeling despite skeletal maturity; what changed with age was not the bone's ability to respond, but the traditional mechanisms (dental movement, alveolar bending) by which orthodontists were trying to create expansion. Miniscrew anchorage eliminates these inefficient pathways. Clinical observation from Orthodontist Mark's practice and others demonstrates that expansion rates in adults using MARPE (0.5–1.0 mm per week after latency) approach those seen in growing patients, confirming that skeletal resistance alone—not biological responsiveness—was the limiting factor.
Skeletal and Dentoalveolar Changes:
MARPE vs. RPE
What the Data Show
A landmark prospective randomized clinical trial enrolling 40 patients (20 per group, mean age 14.1 ± 4.2 years MARPE, 14.0 ± 4.5 years RPE) compared conventional and miniscrew-assisted expansion across identical 35-turn activation protocols, using low-dose CBCT imaging at baseline (T0), immediately post-expansion (T1), and after 3-month consolidation (T2). The results fundamentally support the biomechanical model outlined above. First, midpalatal suture separation frequency was 95% (19/20) in the MARPE group versus 90% (18/20) in RPE—a modest but statistically significant difference that becomes more pronounced as patient age increases beyond the study population. More importantly, MARPE delivered greater skeletal gains: nasal width at the molar region (M-NW) and the greater palatine foramen (GPF) showed significantly larger increases in both the immediate post-expansion and consolidation phases (P < 0.05). This translates to more true skeletal expansion and less reliance on alveolar and dental compensation. Regarding dentoalveolar changes, both groups showed similar crown-level maxillary width changes; however, MARPE demonstrated significantly greater maxillary width at the premolar (PM-MW) and molar (M-MW) levels, reflecting the superior skeletal component. Critically, the MARPE group exhibited lesser buccal displacement of anchor teeth (both mesial and distal roots) across the entire expansion and consolidation timeline (P < 0.05). This means adult patients treated with MARPE not only achieve greater skeletal expansion but also incur fewer dental side effects—less tooth flaring, less alveolar bending, and less need for subsequent correction. The consolidation phase (T2-T0) maintained these gains, with no rebound in either group, suggesting that newly formed bone at the suture is inherently stable.
Who Benefits Most From Adult Palatal
Expansion
Patient Selection and Timing
Successful MARPE in adults requires careful case selection based on skeletal and anatomical criteria, not age alone. The research emphasizes that individual variability in midpalatal suture fusion is substantial and does not correlate directly with chronological age. CBCT imaging is mandatory before treatment planning; cone-beam tomography allows precise assessment of suture morphology, degree of ossification, and identification of any pathological fusion patterns. Ideally, patients selected for MARPE should demonstrate a suture architecture that is continuous (not fragmented) and with visible trabecular bone structure, even if densified. Patients with complete ossification and no trabecular spaces have lower success rates and may require SARPE instead. Beyond suture anatomy, successful candidates exhibit adequate palatal bone thickness (minimum 6–8 mm in the planned miniscrew insertion sites) and sufficient keratinized palatal mucosa (minimum 2–3 mm) to allow miniscrew placement without compromising periodontal health. Transverse maxillary deficiency should be documented through dental casts, CBCT, and functional assessment (e.g., crossbite severity, airway impact). Patients with severe anterior-posterior or vertical skeletal discrepancies may benefit from MARPE as part of a pre-surgical orthodontic protocol; those with primary anterior-posterior concerns alone are less suitable. Age per se is not a contraindication—the research shows efficacy in patients spanning adolescence into early adulthood, and clinical experience suggests benefit extends into the 4th–5th decades, provided skeletal and anatomical criteria are met. Psychological readiness is also important: MARPE requires 8–12 weeks of active expansion followed by 6 months of consolidation retention, with rigorous patient compliance during the critical latency and activation phases.
MARPE as an Alternative to Surgical
Expansion
Why Non-Surgical Matters
For decades, SARPE was the gold standard for adult maxillary expansion, offering reliable skeletal gains at the cost of surgical morbidity. A clinical research series comparing SARPE with and without midpalatal osteotomy in 24 adult patients (14 with split, 10 without) documented efficacy metrics and patient symptomatology. The study confirmed that midpalatal osteotomy improved skeletal separation efficacy (P = 0.00), meaning true bony separation was more complete and predictable when the suture was surgically divided. However, the surgical groups reported similar immediate postoperative discomfort, and non-osteotomy SARPE patients actually reported greater discomfort during appliance activation in the days and weeks following surgery. This counterintuitive finding highlights a key advantage of MARPE: it avoids surgical trauma entirely. MARPE achieves skeletal separation through biological remodeling rather than mechanical fracture, resulting in minimal perioperative morbidity (no surgical incisions, no pain management beyond standard activation discomfort, no infection risk from surgical sites). The trade-off is that MARPE requires careful force calibration and longer active expansion timelines; however, the net patient experience is substantially less invasive. From a clinical perspective, MARPE should be the first-line approach for adult patients meeting anatomical criteria, reserving SARPE for those with severely ossified sutures, inadequate palatal bone anatomy, or failed MARPE attempts. The evidence base increasingly supports this triage, as MARPE success rates (90–95% suture separation) now approach SARPE efficacy while eliminating surgical risk and cost. Orthodontist Mark's clinical protocols reflect this evolution, prioritizing non-invasive skeletal expansion whenever feasible.
The MARPE Treatment
Protocol
Diagnostic Imaging Through Consolidation
Implementation of a successful MARPE protocol begins with comprehensive diagnostic imaging. Cone-beam computed tomography is acquired in both coronal and sagittal planes, with attention to midpalatal suture morphology, palatal bone thickness at planned miniscrew sites (anterior-lateral or mid-palatal positions), and overall maxillary skeletal anatomy. Hard tissue measurements include interpremolar width, intermolar width, nasal width (baseline), and posterior airway dimensions when relevant. Soft tissue photometry and digital cast analysis complete the diagnostic record. Following patient selection and informed consent—emphasizing the 8–12 week active phase and 6-month retention commitment—miniscrews are placed under topical and local anesthesia (typically bilateral placement, 2 screws per side, in the hard palate between tooth roots). Placement depth, angulation, and spacing are critical; the miniscrews must be positioned to receive the expansion appliance arms without impingement on roots or the nasal mucosa. A latency period of 5–7 days follows miniscrew placement to allow tissue integration and initial osseointegration. Expansion activation begins with a protocol of 4 turns on the expansion screw on the day of placement activation and 3 turns per day for 10 days, followed by a 3-day pause. This cycle (activation burst + pause) repeats 4 times, providing approximately 8–10 weeks of active expansion. Activation magnitude can be titrated based on patient comfort and screw stability; if mobility develops, expansion rate is reduced. Throughout expansion, patients are monitored at 2–3 week intervals for screw stability, activation tolerance, suture opening (clinical and radiographic), and periodontal health around screw sites. A repeat CBCT at midpoint expansion confirms suture separation. Upon completion of expansion, the screw is deactivated for 3 turns per day over 10 days to relieve loading. The consolidation phase begins immediately: miniscrews remain in situ (typically 6 months) to allow new bone formation at the opened suture. A retention protocol—either a fixed palatal bar or removable appliance—is applied to prevent relapse. After 6 months, miniscrews are removed under local anesthesia, and retention continues for an additional 6 months. A final CBCT at 14 months post-activation (typical timeline reported in clinical protocols) documents final skeletal position and confirms stability.
Avoiding MARPE Failure:
Key Complications
and Clinical Safeguards
Despite high success rates, MARPE complications and failures do occur, and awareness of common pitfalls is essential for clinical judgment. Miniscrew failure—defined as mobility, infection, or fracture—occurs in approximately 5–10% of placed screws across the literature; this is usually managed by removal and replacement. To minimize screw failure, ensure adequate bone thickness (≥6 mm), appropriate placement angulation (perpendicular to the insertion surface), and meticulous hemostasis and hygiene around the insertion site. Patients with compromised bone density (osteoporosis, bisphosphonate therapy history, chronic corticosteroid use) are at higher risk and should be counseled accordingly. Suture reopening failure—where the suture does not separate despite appliance activation—occurs in approximately 5% of cases, even when anatomical criteria are met; this may reflect underestimated suture ossification or inadequate force vector. If suture separation is not observed on CBCT by midpoint expansion (4–5 weeks), diagnostic imaging should confirm, and force magnitude or screw position should be reassessed. Excessive activation leading to root proximity or mucositis around screw sites can be prevented by regular clinical assessment and adjustment of activation protocols. Relapse following retention removal is uncommon if consolidation retention is maintained for the full 6-month period; premature screw removal or inadequate retention appliance use are major contributors to instability. Patient compliance during the critical expansion phase is paramount; patients who miss activation days or deactivate the screw themselves will not achieve suture separation. Informed consent emphasizing the time commitment and the importance of regular monitoring is essential. Finally, inappropriate case selection—choosing MARPE for a patient with heavily ossified suture or inadequate palatal anatomy—almost guarantees failure; reliance on CBCT assessment and willingness to redirect suitable candidates to SARPE is clinically mature practice.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
What is the optimal age to begin miniscrew-assisted rapid palatal expansion in non-growing patients?
Age per se is not the determining factor; CBCT assessment of midpalatal suture morphology is essential. Patients with continuous trabecular structure respond well even in the 3rd–4th decades. Chronological age alone does not reliably predict suture fusion.
How does MARPE differ biomechanically from conventional RPE in adult patients?
MARPE applies expansion force directly to the skeletal structure via miniscrews, bypassing dental compensation. Conventional RPE relies on tooth movement and alveolar bending, which become the dominant response in adults with fused sutures.
What percentage of adult patients achieve midpalatal suture separation with MARPE?
A randomized clinical trial documented 95% suture separation (19 of 20 patients) with MARPE, compared to 90% with conventional RPE, using identical 35-turn activation protocols.
How much skeletal gain in nasal width can be expected from MARPE in adult expansion?
MARPE consistently produces greater increases in nasal width at the molar region and greater palatine foramen level compared to RPE, with gains maintained through the 3-month consolidation phase.
What are the prerequisites for miniscrew placement during adult palatal expansion?
Hard palate bone thickness of at least 6–8 mm at planned insertion sites, adequate keratinized palatal mucosa (2–3 mm), and absence of severe ossification or pathological fusion patterns confirmed on CBCT.
How long does the active expansion phase typically last, and what is the miniscrew retention timeline?
Active expansion spans 8–12 weeks using a burst-pause protocol. Miniscrews remain in situ for 6 months during consolidation to allow new bone formation and prevent relapse before removal.
Can MARPE be used as an alternative to SARPE in adult patients with significant transverse deficiency?
Yes, MARPE should be first-line for patients meeting anatomical criteria, reserving SARPE for those with heavily ossified sutures or inadequate palatal bone anatomy. MARPE avoids surgical trauma while achieving comparable skeletal separation.
What is the failure rate for miniscrew stability during adult palatal expansion?
Miniscrew failure (mobility, infection, or fracture) occurs in approximately 5–10% of placed screws. Failure is typically managed by removal and replacement without compromising overall treatment outcomes.
How does anchor tooth buccal displacement differ between MARPE and conventional RPE in adults?
MARPE produces significantly less buccal displacement of anchor teeth throughout expansion and consolidation compared to RPE, reducing dental side effects and alveolar compensation.
What retention protocol should follow MARPE miniscrew consolidation in adult patients?
After 6-month miniscrew retention and screw removal, fixed palatal bars or removable appliances maintain expansion stability for an additional 6 months to prevent relapse and ensure long-term skeletal gains.
MARPE represents a paradigm shift in how we approach adult transverse maxillary deficiency. Rather than relegating mature patients to SARPE or accepting dental compensation, clinicians can now deliver true skeletal expansion through miniscrew anchorage. Dr. Mark Radzhabov encourages case review and detailed treatment planning before expansion initiation; access consultation resources and advanced MARPE protocols at ortodontmark.com to refine your adult expansion outcomes.
